Infusion Center of New England - Foxboro

10/10/2025

Today is , a reminder to prioritize your well-being and care for your mind as well as your body. Honoring this day encourages us to practice self-care, reduce stigma, and support one another in maintaining healthy minds.

Small daily practices can make a big difference. Which activity helps you most to relax and recharge?

10/08/2025

👀

It’s happening …

10/07/2025

Thank you for trusting the Neurology Center of New England with your care. We’re honored that our patients choose us time and time again. We remain committed to supporting every journey toward lasting and better .

10/06/2025

Our medical assistants are showing their pink pride today to shine a light on and the importance of early detection.

This month, we stand with the fighters, celebrate the survivors, and honor those we hold close in our hearts. 🩷

10/05/2025

10/03/2025

Struggling to manage high ? Let’s talk about Leqvio, an innovative designed to help lower LDL (“bad”) cholesterol and support long-term .

Leqvio is a preventive given every 3 months, making it easier for patients to stay on track with their cholesterol management. It’s especially helpful for those whose cholesterol remains high despite diet, exercise, or other medications.

High cholesterol levels are a major risk factor for and stroke, even if you feel fine. Call us at (781) 551-5812 option #4 or visit infusioncenterne.com/contact/ to discuss whether this could be the right fit for your care plan.

09/30/2025

A clinical called the C-BEOND Study is looking at whether abobotulinum toxin A injections can help reduce or prevent the number of migraine attacks in adults with chronic .

The C-BEOND Study is recruiting individuals who:

🔬Are aged at least 18 years
🔬 Have been diagnosed with chronic migraine at least 12 months ago
🔬 Started to have migraines before the age of 50 years
🔬 Typically spend at least 15 days a month with a headache out of which at least 8 of these headache days are days with a migraine

Abobotulinum toxin A (Dysport®) is approved for a number of medical and cosmetic uses but not currently for migraine.

For more information about the C-BEOND study, and to see if you may qualify, please email ResearchNCNE@neurocenterne.com or call 781-551-5812 opt. 2.

09/28/2025

Kisunla, FDA approved in 2024, is an anti-amyloid treatment that helps slow the progression of Alzheimer’s disease in patients with mild forms of the condition. A once-monthly infusion may mean more time for the everyday moments that matter.

Because the treatment carries risks—such as brain swelling or bleeding (ARIA)—careful monitoring is essential. Start a conversation with our team, specializing in memory care, at the Neurology Center of New England to learn if Kisunla could be right for you or your loved one.

09/27/2025

We’re recognizing the Alzheimer's Association as a valued . The Alzheimer’s Association is a leading voice for those living with and their families.

They continue to advance research while providing support, education, and resources. We honor the hope, guidance, and strength their work brings to the Alzheimer’s community.

Their free helpline is available 24/7, just call 800-272-3900.

09/26/2025

A clinical called the E-BEOND Study is looking at whether abobotulinum toxin A injections can help reduce or prevent the number of migraine attacks in adults with episodic .

The E-BEOND Study is recruiting individuals who:

🔬 Are aged at least 18 years
🔬 Have been diagnosed with migraine at least 12 months ago
🔬 Started to have migraines before the age of 50 years
🔬 Typically spend less than 15 days a month with a headache out of which at least 6 of these headache days are days with a migraine
🔬 Have previously used, or are currently using, preventative treatment for migraine

Abobotulinum toxin A (Dysport®) is approved for a number of medical and cosmetic uses but not currently for migraine.

For more information about the E-BEOND study, and to see if you may qualify, please email ResearchNCNE@neurocenterne.com or call 781-551-5812 opt. 2.

09/23/2025

We’re ! 🎉 Our new location at 18 Washington Street, Foxboro, MA 02035 is just down the street and designed to elevate patient care, improve access to infusion therapy, and broaden our clinical research initiatives.

Over the next few months, we’ll keep you informed every step of the way, as our top priority is making this transition as smooth as possible for you. This includes sharing any updates to scheduling, parking, or services, so you can continue receiving comprehensive care without interruption.

We can’t wait to welcome you to our new home in the new year!